- CConnexion
RééDOC
75 Boulevard Lobau 54042 NANCY cedex Christelle Grandidier Documentaliste 03 83 52 67 64 0
|
Quality of life in patients with blepharospasm
NAUMANN T; BERG D; ALDERS GL
ACTA NEUROL SCAND , 2001, vol. 103, n° 1, p. 49-52 Doc n°: 98889 Localisation : Documentation IRR Descripteurs : AD33 - MOUVEMENTS ANORMAUX, HE4 - EVALUATION DE LA REEDUCATION READAPTATION, HE5 - SATISFACTION DU PATIENT Administration of botulinum neurotoxin A (BONT/A) is a common and effective treatment of blepharospasm. There is, however, no information regarding the emotional and social well-being of patients with blepharospasm and patient acceptance of BONT/A therapy. The purpose of this study was to investigate aspects of quality of life of patients with blepharospasm and level of patient satisfaction with treatment. Material and methods - Fifty-one patients with blepharospasm who had been treated with BONT/A for years completed a questionnaire providing information about quality of life. Results -Results revealed reductions in social and emotional well-being of patients but, nonetheless, good acceptance of BONT/A therapy. The positive effects of BONT/A therapy were, however, accompanied by fear of a decreasing effect of BONT/A injections. Conclusion - Although the objective findings following BONT/A injections in the treatment of blepharospasm are appreciated by the patients, their well-being is affected by fears and depression. Langue : ANGLAIS Tiré à part : OUI Identifiant basis : 2001214821 |
0
|